298 related articles for article (PubMed ID: 31956565)
21. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
22. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor promotes transforming growth factor-β1-induced epithelial-mesenchymal transition in HK-2 cells through a synergistic effect on Snail.
Xiong J; Sun Q; Ji K; Wang Y; Liu H
Mol Biol Rep; 2014 Jan; 41(1):241-50. PubMed ID: 24203464
[TBL] [Abstract][Full Text] [Related]
24. KLF4 prevents epithelial to mesenchymal transition in human corneal epithelial cells
Fujimoto S; Hayashi R; Hara S; Sasamoto Y; Harrington J; Tsujikawa M; Nishida K
Regen Ther; 2019 Dec; 11():249-257. PubMed ID: 31538102
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen sulfide attenuates paraquat-induced epithelial-mesenchymal transition of human alveolar epithelial cells through regulating transforming growth factor-β1/Smad2/3 signaling pathway.
Bai YW; Ye MJ; Yang DL; Yu MP; Zhou CF; Shen T
J Appl Toxicol; 2019 Mar; 39(3):432-440. PubMed ID: 30265375
[TBL] [Abstract][Full Text] [Related]
26. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
27. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
28. Honokiol inhibits epithelial-mesenchymal transition and hepatic fibrosis via activation of Ecadherin/GSK3β/JNK and inhibition of AKT/ERK/p38/β-catenin/TMPRSS4 signaling axis.
Seo JH; Lee HJ; Sim DY; Park JE; Ahn CH; Park SY; Cho AR; Koo J; Shim BS; Kim B; Kim SH
Phytother Res; 2023 Sep; 37(9):4092-4101. PubMed ID: 37253375
[TBL] [Abstract][Full Text] [Related]
29. Diosmetin prevents TGF-β1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways.
Ge A; Ma Y; Liu YN; Li YS; Gu H; Zhang JX; Wang QX; Zeng XN; Huang M
Life Sci; 2016 May; 153():1-8. PubMed ID: 27101925
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin (1-7) Inhibits Transforming Growth Factor-Β1-Induced Epithelial-Mesenchymal Transition of Human Keratinocyte Hacat Cells in vitro.
Jihu Y; Leng R; Liu M; Ren H; Xie D; Yao C; Yan H
Clin Cosmet Investig Dermatol; 2024; 17():1049-1058. PubMed ID: 38737946
[TBL] [Abstract][Full Text] [Related]
31. Total flavone of
Yang BL; Zhu P; Li YR; Xu MM; Wang H; Qiao LC; Xu HX; Chen HJ
World J Gastroenterol; 2018 Aug; 24(30):3414-3425. PubMed ID: 30122880
[TBL] [Abstract][Full Text] [Related]
32. Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways.
Zhou XL; Xu P; Chen HH; Zhao Y; Shen J; Jiang C; Jiang S; Ni SZ; Xu B; Li L
Sci Rep; 2017 Nov; 7(1):14727. PubMed ID: 29116196
[TBL] [Abstract][Full Text] [Related]
33. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
Yang T; Chen M; Sun T
Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation.
Docherty NG; O'Sullivan OE; Healy DA; Murphy M; O'neill AJ; Fitzpatrick JM; Watson RW
Am J Physiol Renal Physiol; 2006 May; 290(5):F1202-12. PubMed ID: 16368739
[TBL] [Abstract][Full Text] [Related]
36. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
[TBL] [Abstract][Full Text] [Related]
37. Wulong Xiaozheng Wan medicated serum inhibits epithelial-mesenchymal transition in human gastric carcinoma cell line BGC823 by modulation of transforming growth factor-β1/Smad signaling.
Zhang Y; Wang B; Yang L; Li D; Yuan X; Guo X
J Tradit Chin Med; 2019 Jun; 39(3):380-392. PubMed ID: 32186010
[TBL] [Abstract][Full Text] [Related]
38. Numb-PRRL promotes TGF-β1- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer.
Sheng W; Tang J; Cao R; Shi X; Ma Y; Dong M
Cell Death Dis; 2022 Feb; 13(2):173. PubMed ID: 35197444
[TBL] [Abstract][Full Text] [Related]
39. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]